Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−0.10 (-4.89%)
Close on Nov 18, 2026Market cap $4.60MP/E –Yield –
Biodexa Pharmaceuticals shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 54.86B, up 1007.7% from the year before. Over ten years it grew 288.2% a year on average. The highest annual figure on record is 54.86B in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 54.86B | +1007.7% |
| FY2024 | Dec 31, 2024 | 4.95B | +1468.1% |
| FY2023 | Dec 31, 2023 | 316M | +6291.4% |
| FY2022 | Dec 31, 2022 | 5M | +22.7% |
| FY2021 | Dec 31, 2021 | 4M | +88.0% |
| FY2020 | Dec 31, 2020 | 2M | +133.7% |
| FY2019 | Dec 31, 2019 | 1M | +499.8% |
| FY2018 | Dec 31, 2018 | 0M | +19.1% |
| FY2017 | Dec 31, 2017 | 0M | +42.3% |
| FY2016 | Dec 31, 2016 | 0M | +27.8% |
| FY2015 | Dec 31, 2015 | 0M | – |
See a number that looks wrong?